Rizzoli E, de Meeus dArgenteuil C, Fastres A, Roels E, Janssen P, Pure E
Front Vet Sci. 2024; 11:1416124.
PMID: 39188902
PMC: 11346374.
DOI: 10.3389/fvets.2024.1416124.
Sun D, Li W, Ding D, Tan K, Ding W, Wang Z
Cell Death Discov. 2024; 10(1):230.
PMID: 38740736
PMC: 11091202.
DOI: 10.1038/s41420-024-01995-4.
Bukhari M, Patel N, Fontana R, Santiago-Medina M, Jiang Y, Li D
Cell Rep. 2023; 42(10):113302.
PMID: 37862167
PMC: 10742343.
DOI: 10.1016/j.celrep.2023.113302.
Kalaei Z, Manafi-Farid R, Rashidi B, Kiani F, Zarei A, Fathi M
Cell Commun Signal. 2023; 21(1):139.
PMID: 37316886
PMC: 10265921.
DOI: 10.1186/s12964-023-01151-y.
Ji D, Jia J, Cui X, Li Z, Wu A
iScience. 2023; 26(6):106600.
PMID: 37213233
PMC: 10196996.
DOI: 10.1016/j.isci.2023.106600.
The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies.
Dong Y, Zhou H, Alhaskawi A, Wang Z, Lai J, Yao C
Cancers (Basel). 2023; 15(4).
PMID: 36831535
PMC: 9954090.
DOI: 10.3390/cancers15041193.
Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine.
Ke C, Chiu Y, Huang K, Lin C
Int J Mol Sci. 2023; 24(1).
PMID: 36613591
PMC: 9820296.
DOI: 10.3390/ijms24010147.
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?.
Dendl K, Koerber S, Kratochwil C, Cardinale J, Finck R, Dabir M
Cancers (Basel). 2021; 13(19).
PMID: 34638433
PMC: 8508433.
DOI: 10.3390/cancers13194946.
Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review.
Xin L, Gao J, Zheng Z, Chen Y, Lv S, Zhao Z
Front Oncol. 2021; 11:648187.
PMID: 34490078
PMC: 8416977.
DOI: 10.3389/fonc.2021.648187.
and Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes.
Van Rymenant Y, Tanc M, Van Elzen R, Bracke A, de Wever O, Augustyns K
Front Chem. 2021; 9:640566.
PMID: 33996747
PMC: 8114891.
DOI: 10.3389/fchem.2021.640566.
Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the Ga-FAPI PET Prospective Observational Trial.
Kessler L, Ferdinandus J, Hirmas N, Bauer S, Dirksen U, Zarrad F
J Nucl Med. 2021; 63(1):89-95.
PMID: 33931468
PMC: 8717183.
DOI: 10.2967/jnumed.121.262096.
Multimodal Molecular Imaging of the Tumour Microenvironment.
Foray C, Barca C, Backhaus P, Schelhaas S, Winkeler A, Viel T
Adv Exp Med Biol. 2020; 1225:71-87.
PMID: 32030648
DOI: 10.1007/978-3-030-35727-6_5.
In search of definitions: Cancer-associated fibroblasts and their markers.
Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E
Int J Cancer. 2019; 146(4):895-905.
PMID: 30734283
PMC: 6972582.
DOI: 10.1002/ijc.32193.
Whole Tumor Antigen Vaccines: Where Are We?.
Lai-Lai Chiang C, Coukos G, Kandalaft L
Vaccines (Basel). 2015; 3(2):344-72.
PMID: 26343191
PMC: 4494356.
DOI: 10.3390/vaccines3020344.
Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T, Yasui Y, Nishina S, Hara Y, Yanatori I, Tomiyama Y
BMC Gastroenterol. 2015; 15:109.
PMID: 26330349
PMC: 4556412.
DOI: 10.1186/s12876-015-0340-0.
Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F, Qi L, Liu B, Liu J, Zhang H, Che D
PLoS One. 2015; 10(3):e0116683.
PMID: 25775399
PMC: 4361589.
DOI: 10.1371/journal.pone.0116683.
Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.
Tulley S, Chen W
J Biol Chem. 2014; 289(22):15280-96.
PMID: 24727589
PMC: 4140886.
DOI: 10.1074/jbc.M114.568501.
Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer.
Jiang C, Wang W, Yan W, Zhang Y, Yang J, Zhang S
Exp Ther Med. 2012; 2(4):667-673.
PMID: 22977558
PMC: 3440724.
DOI: 10.3892/etm.2011.264.
Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.
Zhu S, Li Y, Mi L, Zhang Y, Zhang L, Gong L
Dig Dis Sci. 2011; 56(12):3569-76.
PMID: 21789540
DOI: 10.1007/s10620-011-1812-x.
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Lee H, Mullins S, Franco-Barraza J, Valianou M, Cukierman E, Cheng J
BMC Cancer. 2011; 11:245.
PMID: 21668992
PMC: 3141768.
DOI: 10.1186/1471-2407-11-245.